Rebeca Martinez
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Pyrimidine-based compounds as promising anticancer agents targeting tumor cell senescence.
Journal: Molecular therapy. Oncology
Published: September 16, 2025
RET Fusion Testing in Patients With NSCLC: The RETING Study.
Journal: JTO clinical and research reports
Published: December 05, 2023
Efficient Identification of Patients With NTRK Fusions Using a Supervised Tumor-Agnostic Approach.
Journal: Archives of pathology & laboratory medicine
Published: February 21, 2023
Pan-TRK Immunohistochemistry: An Example-Based Practical Approach to Efficiently Identify Patients With NTRK Fusion Cancer.
Journal: Archives of pathology & laboratory medicine
Published: August 20, 2020
Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non-Small Cell Lung Carcinoma: the ROSING Study.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: May 10, 2019
Profile of Ventana ALK (D5F3) companion diagnostic assay for non-small-cell lung carcinomas.
Journal: Expert review of molecular diagnostics
Published: April 01, 2016
Comparison of molecular testing methods for the detection of EGFR mutations in formalin-fixed paraffin-embedded tissue specimens of non-small cell lung cancer.
Journal: Journal of clinical pathology
Published: February 07, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026